Credit score: Unsplash/CC0 Public Area
Inside months of Pennsylvania’s medical hashish program including anxiousness as a qualifying situation, that analysis rapidly rose to change into the commonest for hashish certifications, in keeping with a examine by researchers on the College of Pittsburgh and Johns Hopkins College. The examine was printed in Annals of Inside Drugs.
So far, 39 states have medical hashish packages, with continual ache and post-traumatic stress dysfunction (PTSD) traditionally being the commonest and second-most widespread qualifying diagnoses, respectively, amongst contributors. In recent times, a number of states, together with Pennsylvania, have integrated anxiousness into their packages.
“We found that adding anxiety as a qualifying condition fundamentally changed the makeup of Pennsylvania’s medical cannabis program,” mentioned corresponding creator Coleman Drake, Ph.D., affiliate professor within the Division of Well being Coverage and Administration at Pitt’s Faculty of Public Well being.
The researchers analyzed Pennsylvania Division of Well being information on 1,730,600 medical hashish certifications issued from November 2017, when anxiousness problems have been added, to December 2023. These certifications require a doctor go to and annual renewal.
The workforce discovered that the variety of certifications issued every month practically tripled throughout that point. Earlier than the listing of qualifying situations was expanded, continual ache comprised the lion’s share of diagnoses, at 67%, adopted by 16% for PTSD.
After anxiousness was added, these numbers dropped to 41% and 11%, respectively, and anxiousness rapidly grew to become the commonest analysis, at 60%. Some certifications listed a number of situations.
The workforce was not capable of decide how the general dimension of this system was affected, nor what number of contributors had added or switched to anxiousness from one other analysis or have been enrolling in this system for the primary time.
Proof supporting hashish as an efficient therapy for anxiousness problems is scant compared to different qualifying situations, notably continual ache, notes Drake.
“Adding anxiety to the program may inadvertently signal to patients that cannabis is effective for treating it, despite the lack of evidence, which is concerning,” he mentioned.
“At the same time, cannabis may improve some health outcomes, relative to alternative treatments, depending on the individual and their circumstances.” However, as a result of purple tape and funding shortage that has traditionally restricted analysis on hashish—in addition to the dearth of extra granular information out there from medical and adult-use hashish packages—these unknowns persist, he mentioned.
“The urgency in filling these knowledge gaps is pretty clear, given increases in cannabis use over the past decade, and the large changes in cannabis markets, like those we observed in this study,” mentioned Drake.
Different authors on the examine have been Linh Tran and Matthew Eisenberg, Ph.D., of Johns Hopkins College Bloomberg Faculty of Public Well being.
Extra data:
Medical Hashish Certifications After Pennsylvania Added Anxiousness Issues as a Qualifying Situation, Annals of Inside Drugs (2025). DOI: 10.7326/ANNALS-25-01037
Offered by
College of Pittsburgh
Quotation:
Medical hashish program modifications drastically when including anxiousness as a qualifying situation, examine finds (2025, July 7)
retrieved 7 July 2025
from https://medicalxpress.com/information/2025-07-medical-cannabis-drastically-adding-anxiety.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.
